Zoe Guttendorf

Affect Therapeutics is a nation-wide substance use disorder treatment provider for alcohol, marijuana/cannabis, methamphetamine, cocaine, and prescription stimulants. Our wholistic program is delivered through a revolutionary smartphone app that reduces known barriers in access to care and leverages the latest research and technology to achieve incredible results. We use contingency management and other types of rewards systems as engagement techniques as well as harm reduction to keep people working towards their goals. Designed with behavioral engineering and gamification principles, our app stimulates the brains rewards center as people reduce their use of substances and learn to manage the chronic disease of addiction into remission. Accredited by CARF Internation and supported by NIDA and NIH, Affects revolutionary program and technology achieve outcomes more than double of traditional rehab models. Thousands of people who have struggled to break free of addiction have found success with us. We partner with a wide range of organizations who are working to address the nations addiction crisis. We work with referral partners across the treatment sector to provide the appropriate levels of care for each individual. Affect makes care available to communities that do not have access to clinics and it works in a continuum of care so people leaving detox and inpatient can continue to work their recovery programs conveniently and discreetly. Community organizations and partners in the criminal justice system rely on us to support them. Find out more about how Affect works, how you can work with us, and if it can work for you at our website. Our app is free to download and use. The program is covered by Medicaid and we accept many commercial insurance plans. We beat the deadly game of addiction by changing the rules. Win your life back with Affect.

Affect Therapeutics is a nation-wide substance use disorder treatment provider for alcohol, marijuana/cannabis, methamphetamine, cocaine, and prescription stimulants. Our wholistic program is delivered through a revolutionary smartphone app that reduces known barriers in access to care and leverages the latest research and technology to achieve incredible results. We use contingency management and other types of rewards systems as engagement techniques as well as harm reduction to keep people working towards their goals. Designed with behavioral engineering and gamification principles, our app stimulates the brains rewards center as people reduce their use of substances and learn to manage the chronic disease of addiction into remission. Accredited by CARF Internation and supported by NIDA and NIH, Affects revolutionary program and technology achieve outcomes more than double of traditional rehab models. Thousands of people who have struggled to break free of addiction have found success with us. We partner with a wide range of organizations who are working to address the nations addiction crisis. We work with referral partners across the treatment sector to provide the appropriate levels of care for each individual. Affect makes care available to communities that do not have access to clinics and it works in a continuum of care so people leaving detox and inpatient can continue to work their recovery programs conveniently and discreetly. Community organizations and partners in the criminal justice system rely on us to support them. Find out more about how Affect works, how you can work with us, and if it can work for you at our website. Our app is free to download and use. The program is covered by Medicaid and we accept many commercial insurance plans. We beat the deadly game of addiction by changing the rules. Win your life back with Affect.

ARTIS Ventures (AV) partners with entrepreneurs who are driven to impact the world by reshaping and reinventing industries. The team supports its portfolio companies through their entire life-cycle, from initial venture investment to public offering and beyond. As an early leader in the emerging TechBio sector, ARTIS Ventures funds companies at the intersection of computer science and life science, applying engineering principles and data-enabled discovery to the healthcare space. Notable companies the firm has backed include Stemcentrx, Lemonaid Health, Viacyte, Eko Health, Outpace Bio, RadAI, Delix Therapeutics, Freenome, Excision Bio, Modern Meadow, Palantir, YouTube, Cohesity, and many more. For more information visit www.av.co or email contact@av.co.

Quid helps business leaders turn complexity into clarity, and clarity into outcomes. The world doesn’t need more dashboards. Charts, tables, and slides don’t make decisions — people do. That’s why Quid exists: to engineer outcomes, not dashboards. Over 75% of our company are engineers, split between core engineering and outcome engineering. Every line of code, every model, every refinement is built to do one thing: help our customers know what’s happening, why it matters, and what to do next. Quid listens to the market at scale, leveraging billions of conversations, articles, and signals, and translates that noise into clarity. Then we go further: we show you how to act on it. Whether it’s protecting brand health, driving in-season sales, fueling product innovation, or shaping company strategy, Quid raises the bar for what business leaders should demand. We’re not a dashboard company. We’re an outcome engineering organization, relentless in our focus on helping you make smarter and bolder decisions that drive positive outcomes for your business.